Sunshine Biopharma Inc
NASDAQ:SBFM

Watchlist Manager
Sunshine Biopharma Inc Logo
Sunshine Biopharma Inc
NASDAQ:SBFM
Watchlist
Price: 1.43 USD -0.69% Market Closed
Market Cap: 6.5m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

SBFM Price Targets Summary
Sunshine Biopharma Inc

There are no price targets for SBFM.
SBFM Lowest Forecast
Wall Street Target
Not Available
SBFM Average Forecast
Wall Street Target
Not Available
SBFM Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sunshine Biopharma Inc Competitors:
Price Targets
D
DVYSR
Devyser Diagnostics AB
43% Upside
V
VTGN
VistaGen Therapeutics Inc
550% Upside
S
688373
Shanghai MicuRx Pharmaceutical Co Ltd
16% Downside
301047
Sino Biological Inc
22% Upside
D
DVYSR
Devyser Diagnostics AB
43% Upside
V
VTGN
VistaGen Therapeutics Inc
550% Upside
S
688373
Shanghai MicuRx Pharmaceutical Co Ltd
16% Downside
301047
Sino Biological Inc
22% Upside
UTHR
United Therapeutics Corp
35% Upside
TECX
AVROBIO Inc
350% Upside
GLPG
Galapagos NV
26% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
56% Upside

Revenue
Forecast

Revenue Estimate
Sunshine Biopharma Inc

The compound annual growth rate of Sunshine Biopharma Inc's revenue for the next 1 year is 192%.

N/A
Past Growth
192%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sunshine Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sunshine Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
SBFM intrinsic value, competitors valuation, and company profile.
DCF Valuation
SBFM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SBFM stock valuation using valuation multiples.
Wall Street Estimates
SBFM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SBFM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SBFM's stock price target?
Not Available

SBFM doesn't have any price targets made by Wall Street professionals.

What is Sunshine Biopharma Inc's Revenue forecast?
Projected CAGR
192%

The compound annual growth rate of Sunshine Biopharma Inc's revenue for the next 1 year is 192%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.